Skip to main content
Watch Insiders

Corporate insider profile

Christopher Hite Insider Trades

Latest reported as EVP & Chairman, Partnering of Royalty Pharma plc (RPRX).

Purchase filings
0
Reported companies
1
Net open-market value
-$27,355,098.00
Latest transaction
Sep 22, 2026

Affiliated corporations

Reported company relationships

RPRXLatest reported

Royalty Pharma plc

EVP & Chairman, Partnering

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 22, 2026Royalty Pharma plc (RPRX)EVP & Chairman, PartneringSale100,000$58.53$5,853,100
Aug 18, 2026Royalty Pharma plc (RPRX)EVP & Chairman, PartneringSale100,000$59.97$5,997,250
Jun 30, 2026Royalty Pharma plc (RPRX)EVP & Chairman, PartneringSale130,000$56.50$7,345,468
Jun 23, 2026Royalty Pharma plc (RPRX)EVP & Chairman, PartneringSale150,000$54.40$8,159,280